相关实验视频

Updated: Aug 7, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.7K

解读与细胞死亡相关的特征,用于预测肺状细胞癌的预后和免疫治疗反应

Guangxian Mao1, Dongyong Yang2, Bin Liu3

  • 1Department of Thoracic Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, China.

Respiratory research
|July 6, 2023
PubMed
概括

一个新的细胞死亡指数 (CDI) 签名预测了肺状细胞癌 (LUSC) 的预后和免疫治疗反应. 该工具有助于评估患者的治疗结果,并指导LUSC的治疗策略.

关键词:
细胞死亡 细胞死亡细胞因子 (cytokines) 是一种细胞因子.免疫治疗反应 免疫治疗反应肺状细胞癌是肺的状细胞癌.预测签名的预测签名

更多相关视频

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.6K
Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

492

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...